GILD vs SCNI
Gilead Sciences, Inc. - Common Stock · Scinai Immunotherapeutics Ltd. - American Depositary Shares
Relative return (rebased to 100)
Key stats
| Metric | GILD | SCNI |
|---|---|---|
| Price | $151.17 | $1.18 |
| Market Cap | $187.44B | $16.37B |
| P/E | 22.03 | — |
| P/B | 15.85 | 2020.24 |
| P/S | 6.37 | 12486.67 |
| ROE | 71.9% | -102.5% |
| Net Margin | 28.9% | -633.6% |
| Gross Margin | — | -202.3% |
| Revenue Growth | 2.4% | 99.2% |
| Dividend Yield | 2.09% | — |
| EPS | $6.86 | -$0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.